Serial measurements of transient evoked otoacoustic emissions (TEOAEs) in healthy newborns and in newborns with perinatal infection

International Journal of Pediatric Otorhinolaryngology

Volumn 27, Issue 3, 1993, Pages 245-254

  Zorowka, P ^a   Schmitt, H J ^a   Eckel, H E ^a   Lippert, K L ^a   Schonberger W ^a   Merz, E ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Aminoglycosides; Newborns; Otoacoustic emissions; Perinatal infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFOTAXIME;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; HEARING IMPAIRMENT; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; OTOTOXICITY; PERINATAL INFECTION; PRIORITY JOURNAL;

AMPICILLIN; ANTIBIOTICS, AMINOGLYCOSIDE; AUDITORY PERCEPTION; BACTERIAL INFECTIONS; CEFOTAXIME; COCHLEA; COMPARATIVE STUDY; EVOKED POTENTIALS, AUDITORY; FEMALE; FOLLOW-UP STUDIES; HUMAN; INFANT, NEWBORN; MALE; NETILMICIN; REFLEX, ACOUSTIC; REPRODUCIBILITY OF RESULTS; TOBRAMYCIN;

EID: 0027446652     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5876(93)90230-Z     Document Type: Article

References (47)

1. Hearing loss in very low birthweight infants treated with neonatal intensive care
2. Joint committee on infant hearing. Position Statement 1990
3. Postnatal development of renal function in preterm and full-term infants
4. Ototoxicity of aminoglycoside antibiotics in infants and children
5. Control of intracellular calcium by ATP in isolated outer hair cells of the guinea-pig cochlea
6. Evoked oto-acoustic emissions from adults and infants: Clinical applications
7. An advanced cochlear echo technique suitable for infant screening
8. Combined effects of noise and kanamycin
9. Supra-normal sensitivity to ototoxic antibiotic of the developing rat cochlea
10. Action toxique vestibulaire et cochléaire de la streptomycine au point de vue expérimental
11. Intensive treatment of Pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin
12. Ototoxicity of amino-glycoside antibiotics in long-term treatment for cystic fibrosis
13. An active process in cochlear mechanics
14. Evoced acoustic emissions Clinical application
15. Aminoglycoside ototoxicity in the neonatal period: Possible etiologic factor in delayed postural control
16. Pharmacokinetics and ototoxicity of gentamicin, tobramycin and amikacin
17. Experimentelle Untersuchungen zur Ototoxizität der Aminoglykosid-Antibiotika und ihre klinische Bedeutung
18. Ototoxicity in neonates treated with gentamicin and kanamycin: results of a four-year controlled follow-up study
19. Prospective controlled evaluation of auditory function in neonates given netilmicin or amikacin
20. Oto-akustische Emissionen und ihre Bedeutung für die Innenohrforschung
21. Behavioral measures
22. Anatomical correlates of functional recovery in the avian inner ear following aminoglycoside ototoxicity
23. Repeatability of transiently evoked otoacoustic emissions in normally hearing humans
24. Inner ear antibodies in patients with rapidly progressive sensorineural hearing loss
25. Intensive care nursery noise and its influence on newborn hearing screening
26. Familial occurrence of drug induced hearing loss
27. Stimulated acoustic emissions from within the human auditory system
28. Auditory brainstem responses in perinatal asphyxia
29. Dual action of ototoxic antibiotics on sensory hair cells
30. Cochlear micromechanics in understanding otoacoustic emission
31. Clinical applications of otoacoustic emissions
32. Ototoxic medication in premature children
33. Auditory function in newborn intensive care unit patients revealed by auditory brain-stem potentials
34. Aminoglycoside toxicity in infants and children
35. Aetiology of deafness in children
36. Spontaneous, click-, and toneburst-evoked otoacoustic emissions from normal ears
37. Perfusion of the inner ear with streptomycin
38. Double-blind comparison on the nephrotoxicity and auditory toxicity of gentamicin and tobramycin
39. Relationship of gentamicin serum concentrations to gestational age in preterm and term neonates
40. High dosage tobramycin treatment of children with cystic fibrosis: Bacteriological effect and clinical ototoxicity
41. Autoimmunity and inner ear disorders: An immune-complex mediated sensorineural hearing loss
42. Motile responses in outer hair cells
43. Outer hair cells as fast and slow cochlear amplifiers with a bidirectional transduction cycle
44. Transduktions- und Motorstörungen kochleärer Haarzellen bei M.Menière und Aminoglykosidschwerhörigkeit
45. Untersuchungen zur kochleären Funktion mitttels Tonschwellenaudiometrie und otoakustischer Emissionen 6 Jahre nach Aminoglykosidtherapie. 88. Jahrestag Dt. Ges. Kinderheilk., Hamburg 1992
46. Evoked otoacoustic emissions and pure tone threshold audiometry in patients receiving cisplatinum therapy